Peregrine Pharmaceuticals shares owned by Royce & Associates
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Royce & Associates
from 13F filings
Historical chart of Royce & Associates investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Royce & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $9.0M | 789k | 11.38 |
| 2024-06-30 | $5.2M | 732k | 7.14 |
| 2024-03-31 | $4.3M | 638k | 6.70 |
| 2023-12-31 | $3.2M | 498k | 6.50 |
| 2023-09-30 | $2.6M | 278k | 9.44 |
| 2023-06-30 | $4.2M | 303k | 13.97 |
| 2023-03-31 | $5.7M | 303k | 18.76 |
| 2022-12-31 | $3.5M | 256k | 13.77 |
| 2022-09-30 | $4.1M | 214k | 19.12 |
| 2022-06-30 | $5.0M | 330k | 15.26 |
| 2022-03-31 | $7.7M | 378k | 20.37 |
| 2021-12-31 | $5.5M | 189k | 29.18 |
| 2021-09-30 | $4.9M | 228k | 21.57 |
| 2021-06-30 | $5.9M | 231k | 25.65 |
| 2021-03-31 | $5.0M | 275k | 18.23 |
| 2020-12-31 | $3.2M | 279k | 11.54 |
| 2020-09-30 | $2.0M | 257k | 7.62 |
| 2020-06-30 | $1.7M | 257k | 6.56 |
| 2020-03-31 | $1.5M | 299k | 5.11 |
| 2019-12-31 | $2.6M | 334k | 7.67 |
| 2019-09-30 | $1.8M | 334k | 5.30 |
| 2019-06-30 | $1.7M | 300k | 5.60 |